Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.
Vergis R, Corbishley CM, Norman AR, Bartlett J, Jhavar S, Borre M, Heeboll S, Horwich A, Huddart R, Khoo V, Eeles R, Cooper C, Sydes M, Dearnaley D, Parker C. Vergis R, et al. Among authors: corbishley cm. Lancet Oncol. 2008 Apr;9(4):342-51. doi: 10.1016/S1470-2045(08)70076-7. Epub 2008 Mar 17. Lancet Oncol. 2008. PMID: 18343725 Free article.
Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalation.
Vergis R, Corbishley CM, Thomas K, Horwich A, Huddart R, Khoo V, Eeles R, Sydes MR, Cooper CS, Dearnaley D, Parker C. Vergis R, et al. Among authors: corbishley cm. Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):35-41. doi: 10.1016/j.ijrobp.2009.07.1728. Epub 2010 Jan 21. Int J Radiat Oncol Biol Phys. 2010. PMID: 20092961 Clinical Trial.
Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer.
Wilkins A, Stuttle C, Hassan S, Blanchard C, Cruickshank C, Griffin C, Probert J, Corbishley CM, Parker C, Dearnaley D, Hall E. Wilkins A, et al. Among authors: corbishley cm. Clin Transl Radiat Oncol. 2018 Feb 16;10:1-6. doi: 10.1016/j.ctro.2018.02.002. eCollection 2018 Mar. Clin Transl Radiat Oncol. 2018. PMID: 29928699 Free PMC article.
Signet ring cell carcinoma in the prostate.
Kendall A, Corbishley CM, Pandha HS. Kendall A, et al. Among authors: corbishley cm. Clin Oncol (R Coll Radiol). 2004 Apr;16(2):105-7. doi: 10.1016/j.clon.2003.10.004. Clin Oncol (R Coll Radiol). 2004. PMID: 15074731
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer.
Wilkins AC, Gusterson B, Szijgyarto Z, Haviland J, Griffin C, Stuttle C, Daley F, Corbishley CM, Dearnaley DP, Hall E, Somaiah N; CHHiP Trial Investigators. Wilkins AC, et al. Among authors: corbishley cm. Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):309-315. doi: 10.1016/j.ijrobp.2018.01.072. Epub 2018 Feb 3. Int J Radiat Oncol Biol Phys. 2018. PMID: 29559283 Free PMC article. Clinical Trial.
Dynamic contrast-enhanced MRI for prostate cancer localization.
Jackson AS, Reinsberg SA, Sohaib SA, Charles-Edwards EM, Jhavar S, Christmas TJ, Thompson AC, Bailey MJ, Corbishley CM, Fisher C, Leach MO, Dearnaley DP. Jackson AS, et al. Among authors: corbishley cm. Br J Radiol. 2009 Feb;82(974):148-56. doi: 10.1259/bjr/89518905. Br J Radiol. 2009. PMID: 19168692
Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators.
Edwards SM, Dunsmuir WD, Gillett CE, Lakhani SR, Corbishley C, Young M, Kirby RS, Dearnaley DP, Dowe A, Ardern-Jones A, Kelly J, Spurr N, Barnes DM, Eeles RA. Edwards SM, et al. Among authors: corbishley c. Int J Cancer. 1998 Sep 25;78(1):1-7. doi: 10.1002/(sici)1097-0215(19980925)78:1<1::aid-ijc1>3.0.co;2-u. Int J Cancer. 1998. PMID: 9724085
116 results